The Daily Byte
Breaking
Welcome to The Daily Byte — real stories from across Pakistan.
Saturday, 21 November 2026 · Pakistan

The Daily Byte

Stories from Pakistan that deserve to be heard
Minor UK News

Pancreatic cancer pill clears tumours in 1 in 12

By The Daily Byte ·20 Nov 2026 ·2 min read
CT scans before and after treatment with daraxonrasib plus chemotherapy, showing tumours that are no longer visible

A once-a-day pill for advanced pancreatic cancer has wiped out the disease in about one in 12 patients when combined with chemotherapy, results presented on Friday show.

In the trial, 61 people newly diagnosed with pancreatic cancer that had already spread took daraxonrasib daily with two standard chemotherapy drugs, gemcitabine and nab-paclitaxel. Tumours shrank or disappeared in 60.7% of patients; in 8.2% — about one in 12 — they could no longer be seen on scans. Tumours stopped growing in 90.2% over a typical 18-month follow-up.

Closest to cure

Dr Wungki Park, of Memorial Sloan Kettering Cancer Centre in New York, told the Press Association he had never seen such responses, calling them a “massive, massive breakthrough”. “In about one in 12 patients, it completely disappeared,” he said. Asked if those patients were cured, he said: “This is the closest to cure.”

One year on, 76.6% of patients were still alive, against around 40% to 45% given chemotherapy alone. Tumours took 12.8 months on average to return or grow again.

How the drug works

Daraxonrasib locks onto the mutated KRAS gene, found in more than nine in 10 pancreatic tumours, which tells cancer cells to grow. Switching off that signal can stop tumours spreading.

Caution and next steps

The pill is not yet a cure, doctors stressed, and how long it holds the disease back is unknown. Pancreatic Cancer UK's Dr Madina Kara called it “a small, initial study” but said the results show the combination “can be effective”. More trials are needed before the NHS can assess it.

Sources: Press Association via Grimsby Telegraph; Brit Brief.